title: [Tumor necrosis factor modulators in the treatment of rheumatoid arthritis].
authors.affiliation: yrjo.konttinen@helsinki.fi
authors.forename: Y T
authors.initials: YT
authors.lastname: Konttinen
authors.forename: H
authors.initials: H
authors.lastname: Valleala
authors.forename: V
authors.initials: V
authors.lastname: Honkanen
authors.forename: J
authors.initials: J
authors.lastname: Törnwall
authors.forename: E K
authors.initials: EK
authors.lastname: Tensing
authors.forename: T
authors.initials: T
authors.lastname: Sorsa
authors.forename: D
authors.initials: D
authors.lastname: Nordström
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D014409:Tumor Necrosis Factor-alpha
vernacular_title: Tuumorinekroositekijämodulaattorit nivelreuman hoidossa.